Total Payments
$470.85
2022 Payments
$27.74
Companies
8
Transactions
28
Medicare Patients
17,400
Medicare Billing
$2.3M
Payment Breakdown by Category
Food & Beverage$470.85 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $470.85 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $295.32 | 18 | $0 (2021) |
| Shire North American Group Inc | $68.64 | 4 | $0 (2017) |
| Ardelyx, Inc. | $27.74 | 1 | $0 (2022) |
| Alfasigma USA, Inc. | $20.20 | 1 | $0 (2020) |
| Daiichi Sankyo Inc. | $19.74 | 1 | $0 (2020) |
| Mauna Kea Technologies, Inc. | $16.87 | 1 | $0 (2021) |
| UCB, Inc. | $11.40 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $10.94 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $27.74 | 1 | Ardelyx, Inc. ($27.74) |
| 2021 | $147.73 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($130.86) |
| 2020 | $73.68 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($33.74) |
| 2019 | $76.74 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($65.80) |
| 2018 | $64.92 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($64.92) |
| 2017 | $80.04 | 5 | Shire North American Group Inc ($68.64) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/13/2022 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/24/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $0.95 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/23/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/22/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/21/2021 | Takeda Pharmaceuticals U.S.A., Inc. | MOTEGRITY (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/25/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/01/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/03/2021 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $11.41 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/20/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/19/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/09/2021 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| 06/16/2020 | Alfasigma USA, Inc. | — | Food and Beverage | In-kind items and services | $20.20 | General |
| 02/19/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/14/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/11/2020 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Anemia | ||||||
| 11/05/2019 | Merck Sharp & Dohme Corporation | ZINPLAVA (Biological), RENFLEXIS | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/04/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Lower GI | ||||||
| 03/11/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $8.66 | General |
| Category: Upper GI | ||||||
| 02/18/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Lower GI | ||||||
| 02/12/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Lower GI | ||||||
| 12/18/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Entyvio (Biological) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Lower GI | ||||||
| 06/20/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Upper GI | ||||||
| 02/13/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Dexilant (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Upper GI | ||||||
| 12/14/2017 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/05/2017 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 1,371 | 2,495 | $648,845 | $132,671 |
| 2022 | 7 | 3,682 | 8,776 | $4.0M | $405,267 |
| 2021 | 6 | 6,897 | 16,342 | $8.3M | $991,987 |
| 2020 | 7 | 5,450 | 13,157 | $6.4M | $741,804 |
Total Patients
17,400
Total Services
40,770
Medicare Billing
$2.3M
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 794 | 1,780 | $489,740 | $90,715 | 18.5% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 268 | 297 | $68,544 | $23,657 | 34.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 115 | 119 | $19,992 | $6,953 | 34.8% |
| 88360 | Microscopic genetic analysis of tumor, manual | Office | 2023 | 60 | 60 | $19,680 | $5,148 | 26.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 97 | 197 | $38,415 | $3,501 | 9.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 26 | 30 | $7,350 | $2,130 | 29.0% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 11 | 12 | $5,124 | $567.04 | 11.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 1,474 | 6,041 | $3.2M | $276,893 | 8.7% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 604 | 650 | $283,092 | $50,671 | 17.9% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 923 | 990 | $313,258 | $46,817 | 14.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 292 | 620 | $118,747 | $17,315 | 14.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 288 | 311 | $117,724 | $8,962 | 7.6% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 23 | 29 | $12,260 | $1,860 | 15.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 20 | 72 | $10,410 | $1,574 | 15.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 30 | 34 | $6,071 | $918.99 | 15.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2022 | 28 | 29 | $1,689 | $256.36 | 15.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 3,212 | 12,276 | $6.7M | $679,313 | 10.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 1,659 | 1,874 | $788,860 | $152,876 | 19.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2021 | 1,817 | 1,946 | $658,282 | $122,887 | 18.7% |
| 0097U | Test for detection of gastrointestinal disease-causing organism using amplified probe | Office | 2021 | 60 | 61 | $85,345 | $22,145 | 25.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 121 | 137 | $66,383 | $12,102 | 18.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2021 | 28 | 48 | $20,190 | $2,663 | 13.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 2,622 | 10,043 | $5.2M | $511,700 | 9.8% |
| 88342 | Tissue or cell analysis by immunologic technique | Office | 2020 | 1,109 | 1,228 | $494,068 | $93,707 | 19.0% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2020 | 1,453 | 1,555 | $498,854 | $86,432 | 17.3% |
About Dr. Karin Berg, MD
Dr. Karin Berg, MD is a Anatomic Pathology healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740220953.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karin Berg, MD has received a total of $470.85 in payments from pharmaceutical and medical device companies, with $27.74 received in 2022. These payments were reported across 28 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($470.85).
As a Medicare-enrolled provider, Berg has provided services to 17,400 Medicare beneficiaries, totaling 40,770 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Anatomic Pathology
- Other Specialties Anatomic Pathology, Anatomic Pathology
- Location Memphis, TN
- Active Since 06/07/2006
- Last Updated 09/06/2023
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1740220953
Products in Payments
- ENTYVIO (Biological) $137.17
- Entyvio (Biological) $66.18
- GATTEX (Drug) $64.81
- Dexilant (Drug) $51.60
- IBSRELA (Drug) $27.74
- INJECTAFER (Drug) $19.74
- MOTEGRITY (Drug) $16.02
- LIALDA (Drug) $15.24
- Amitiza (Drug) $12.94
- Cimzia (Drug) $11.40
- ZINPLAVA (Biological) $10.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in Memphis
Dr. James Downing, Md, MD
Anatomic Pathology — Payments: $4,298
Anatomic Pathology $4,298
Jeffery Klco, M.d, M.D
Anatomic Pathology — Payments: $2,368
Anatomic Pathology $2,368
Dr. Marianna Szabo, Md, MD
Anatomic Pathology — Payments: $314.17
Anatomic Pathology $314.17
Dr. Xianfeng Zhao, M.d, M.D
Anatomic Pathology — Payments: $229.16
Anatomic Pathology $229.16
Jason Chiang, Md, Phd, MD, PHD
Anatomic Pathology — Payments: $24.77
Anatomic Pathology $24.77
Dr. Jesse Jenkins, Md, MD
Anatomic Pathology
Anatomic Pathology